# Numan

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/numan

- Industry: Healthcare IT
- Headquarters: London, UK
- Website: https://www.numan.com/
- Total disclosed funding: $69M
- Latest round: Series B (Jul 21, 2025)
- Investors on record: 8

## About

Founded in 2018 and based in London, UK, Vir Health Limited, trading under the name Numan is a health technology company that provides innovative health solutions focusing on men's health issues and personalized treatments.Vir Health Limited specializes in delivering health and wellness services, particularly for men. Founded in 2018 in London, UK, by Sokratis Papafloratos, the firm has engaged in 4 significant deals. In July 2025, Vir Health Limited raised USD 60 million in series B funding led by new investor Big Pi Ventures, with participation from another new investor Endeavor Catalyst. Returning investors White Star Capital and Novator also participated in the round. The round was part of a larger USD 90 million series B funding. Vir Health Limited offers a variety of health and wellness products aimed at addressing common health concerns. Their services include personalized blood tests and treatments for issues like erectile dysfunction and low testosterone, utilizing clinically-proven medications alongside consultations from medical professionals. The company focuses on providing comprehensive solutions that tackle both symptoms and underlying causes, enhancing the overall health and well-being of their clients in the UK market.In the most recent year, Vir Health Limited reported a revenue of USD 37.17 mn, accompanied by an EBITDA of USD -8.27 mn. The company operates on a direct-to-consumer model, offering subscription-based health services that include personalized consultations and medication deliveries, ensuring a user-friendly experience and competitive pricing for their range of health solutions. The company will use the July 2025 funding for further growth and development.

## Funding rounds

- Series B, Jul 21, 2025, $31M — Novator, White Star Capital, Endeavor Catalyst, Big Pi Ventures
- Series B, Sep 13, 2021, $30M — VNV Global, Novator, White Star Capital, Colle Capital, Anthemis Exponential Ventures, Hanwha Investment & Securities
- Series A, Sep 10, 2020, $7.7M — VNV Global, Novator, Colle Capital, Anthemis Exponential Ventures
- Seed, Feb 13, 2019 — VNV Global

## Investors

- VNV Global (https://capitalatlas.ai/funds/vnv-global) — Seed, Series A, Series B
- Novator (https://capitalatlas.ai/funds/novator) — Series A, Series B
- Colle Capital (https://capitalatlas.ai/funds/colle-capital) — Series A, Series B
- Anthemis Exponential Ventures — Series A, Series B
- White Star Capital (https://capitalatlas.ai/funds/white-star-capital) — Series B
- Hanwha Investment & Securities (https://capitalatlas.ai/funds/hanwha-investment-securities) — Series B
- Endeavor Catalyst (https://capitalatlas.ai/funds/endeavor-catalyst) — Series B
- Big Pi Ventures (https://capitalatlas.ai/funds/big-pi-ventures) — Series B